Piflufolastat ¹⁸F

Chemical formula: C₁₈H₂₃FN₄O₈  Molecular mass: 441.153 g/mol  PubChem compound: 52950901

Therapeutic indications

Piflufolastat ¹⁸F is indicated for:

Detection of prostate-specific membrane antigen positive lesions in patients with prostate cancer

Population group: men, only adults (18 years old or older)

Piflufolastat (18F) is for diagnostic use only.

Piflufolastat (18F) is indicated for the detection of prostate-specific membrane antigen (PSMA) positive lesions with positron emission tomography (PET) in adults with prostate cancer (PCa) in the following clinical settings:

  • Primary staging of patients with high-risk PCa prior to initial curative therapy,
  • To localize recurrence of PCa in patients with a suspected recurrence based on increasing serum prostate-specific antigen (PSA) levels after primary treatment with curative intent.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2023: PYLCLARI Solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈